11-hydroxy-delta(9)-tetrahydrocannabinol has been researched along with Cannabis Abuse in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McMillin, GA; Metz, TD; Scroggin, TL; Wu, F | 1 |
| Bonnet, U; Ochwadt, R; Scherbaum, N; Specka, M; Stratmann, U | 1 |
| Bosker, WM; Goodwin, RS; Hirvonen, J; Huestis, MA; Karschner, EL; Ramaekers, JG; Swortwood, MJ | 1 |
| Bonnet, U; Borda, T; Scherbaum, N; Specka, M | 1 |
| Abraham, TT; Cadet, JL; Darwin, WD; Herning, R; Huestis, MA; Lowe, RH | 1 |
| Darwin, WD; Goodwin, RS; Huestis, MA; Karschner, EL; Wright, S | 1 |
| Gorelick, DA; Huestis, MA; Karschner, EL; Schwope, DM | 1 |
| Bonnet, D; Darwin, WD; Goodwin, RS; Gorelick, DA; Huestis, MA; Kelly, DL; Liu, F; McMahon, RP; Ortemann-Renon, C; Schwilke, E; Schwope, DM | 1 |
| Arendt, M; Fohlmann, A; Hjorthøj, CR; Larsen, AM; Nordentoft, M | 1 |
| Fraser, AD; Worth, D | 1 |
| Augsburger, M; Buclin, T; Giroud, C; Mangin, P; Ménétrey, A; Sanchez-Mazas, P | 1 |
3 trial(s) available for 11-hydroxy-delta(9)-tetrahydrocannabinol and Cannabis Abuse
| Article | Year |
|---|---|
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
Topics: Adult; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Mouth Mucosa; Plant Extracts; Young Adult | 2011 |
Antagonist-elicited cannabis withdrawal in humans.
Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Male; Marijuana Abuse; Mass Spectrometry; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome; Young Adult | 2011 |
Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clin
Topics: Biomarkers; Chromatography, High Pressure Liquid; Dronabinol; Female; Humans; Male; Marijuana Abuse; Psychotic Disorders; ROC Curve; Self Report; Substance Abuse Detection | 2012 |
8 other study(ies) available for 11-hydroxy-delta(9)-tetrahydrocannabinol and Cannabis Abuse
| Article | Year |
|---|---|
Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Four Cannabinoids in Umbilical Cord Tissue.
Topics: Biomarkers; Calibration; Cannabinoids; Cannabinol; Chromatography, Liquid; Dronabinol; Enzyme-Linked Immunosorbent Assay; Female; Humans; Limit of Detection; Marijuana Abuse; Marijuana Smoking; Pregnancy; Reference Standards; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry; Umbilical Cord | 2018 |
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
Topics: Adult; Dronabinol; Female; Humans; Male; Marijuana Abuse; Patient Admission; Prognosis; Prospective Studies; Statistics as Topic; Substance Withdrawal Syndrome; Young Adult | 2014 |
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Topics: Adolescent; Adult; Aged; Automobile Driving; Cannabis; Dronabinol; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Psychomotor Performance; Psychotropic Drugs; Substance Abuse Detection; Young Adult | 2016 |
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
Topics: Cannabis; Comorbidity; Dronabinol; Female; Humans; Inpatients; Male; Marijuana Abuse; Mental Disorders; Prospective Studies; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 2015 |
Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Topics: Adult; Biomarkers; Chronic Disease; Dronabinol; Ethnicity; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Marijuana Abuse; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2009 |
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Female; Glucuronides; Humans; Male; Marijuana Abuse; Middle Aged; Substance Abuse Detection; Young Adult | 2011 |
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
Topics: Creatinine; Dronabinol; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Marijuana Abuse; Substance Abuse Detection | 2004 |
Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.
Topics: Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Plasma; Postmortem Changes; Substance Abuse Detection | 2001 |